Imperial joins the SOLVE consortium to tackle the urgent lack of effective osteoarthritis treatments.
Backed by £3m from @arthritisuk.bsky.social the team will identify patient subgroups to personalise care.👇
www.imperial.ac.uk/news/article...
The SOLVE consortium will aim to identify subgroups of osteoarthritis in order to better match treatments to individuals and improve their quality of...